Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Hwang, Sangyoun [1 ]
Woo, Hyun Young [2 ]
Heo, Jeong [2 ]
Kim, Hyung Jun [1 ]
Park, Young Joo [2 ]
Yi, Kiyoun [2 ]
Lee, Yu Rim [3 ]
Park, Soo Young [3 ]
Jang, Byoung Kuk [4 ]
Chung, Woo Jin [4 ]
Tak, Won Young [3 ]
机构：
[1] Dongnam Inst Radiol & Med Sci, Busan, South Korea
[2] Pusan Natl Univ Hosp, Busan, South Korea
[3] Kyungpook Natl Univ Hosp, Daegu, South Korea
[4] Keimyung Univ, Dongsan Hosp, Daegu, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-137
引用
收藏
页码：S588 / S588
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Woo, Hyun Young
    Hwang, Sangyoun
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Ki Youn
    Lee, Yu Rim
    Park, Soo Young
    Chung, Woo Jin
    Jang, Byoung-Kuk
    Tak, Won Young
    [J]. HEPATOLOGY, 2023, 78 : S1880 - S1881
  • [2] Real-world experience of atezolizumab/bevacizumab in hepatocellular carcinoma
    Ha, Yeonjung
    Cheon, Jaekyung
    Hwang, Seong Gyu
    Chon, Hong Jae
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S526 - S527
  • [3] Real-world experience of atezolizumab and bevacizumab for treatment of advanced hepatocellular carcinoma in a single tertiary center
    Raharjo, C. V.
    Joseph, R.
    Stratton, E.
    Levy, M.
    Prakoso, E.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 22 - 22
  • [4] Real-world systemic treatment patterns of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma (HCC)
    Singal, A. G.
    Ozgurdal, K.
    Fan, X.
    Vassilev, Z.
    Chen, C-C.
    Multani, J. K.
    Zhou, Z.
    He, J.
    Pisa, F.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S867 - S867
  • [5] Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma
    Hwang, Sang Youn
    Woo, Hyun Young
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Ki Youn
    Lee, Yu Rim
    Park, Soo Young
    Chung, Woo Jin
    Jang, Byoung Kuk
    Tak, Won Young
    [J]. CANCERS, 2024, 16 (04)
  • [6] Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.
    Bezalel, Nomi
    Davidov, Yana
    Likhter, Mariya
    Ezra, Oranit Cohen
    Inbar, Yael
    Halpern, Naama
    Ben Boursi
    Beller, Tamar
    Pery, Ron
    Shmueli, Einat S.
    Nachmany, Ido
    Ben Ari, Ziv
    Margalit, Ofer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    Takeda, Soichi
    Namisaki, Tadashi
    Tsuji, Yuki
    Fujimoto, Yuki
    Murata, Koji
    Enomoto, Masahide
    Fujinaga, Yukihisa
    Nishimura, Norihisa
    Kitagawa, Koh
    Takaya, Hiroaki
    Kaji, Kosuke
    Inoue, Takashi
    Kawaratani, Hideto
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    [J]. ANTICANCER RESEARCH, 2022, 42 (11) : 5465 - 5473
  • [8] INITIAL EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE
    Iwamoto, Hideki
    Shimose, Shigeo
    Takashi, Niizeki
    Noda, Yu
    Shirono, Tomotake
    Nakano, Masahito
    Okamura, Shusuke
    Kamachi, Naoki
    Suzuki, Hiroyuki
    Kuromatsu, Ryoko
    Koga, Hironori
    Torimura, Takuji
    [J]. HEPATOLOGY, 2021, 74 : 652A - 652A
  • [9] Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice
    Iwamoto, Hideki
    Shimose, Shigeo
    Noda, Yu
    Shirono, Tomotake
    Niizeki, Takashi
    Nakano, Masahito
    Okamura, Shusuke
    Kamachi, Naoki
    Suzuki, Hiroyuki
    Sakai, Miwa
    Kajiwara, Akira
    Itano, Satoshi
    Tanaka, Masatoshi
    Yamaguchi, Taizo
    Kuromatsu, Ryoko
    Koga, Hironori
    Torimura, Takuji
    [J]. CANCERS, 2021, 13 (11)
  • [10] Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
    Sae Yumita
    Sadahisa Ogasawara
    Miyuki Nakagawa
    Susumu Maruta
    Tomomi Okubo
    Norio Itokawa
    Yotaro Iino
    Masamichi Obu
    Yuki Haga
    Atsuyoshi Seki
    Tadayoshi Kogure
    Takamasa Ishino
    Keita Ogawa
    Kisako Fujiwara
    Terunao Iwanaga
    Naoto Fujita
    Takafumi Sakuma
    Ryuta Kojima
    Hiroaki Kanzaki
    Keisuke Koroki
    Masanori Inoue
    Kazufumi Kobayashi
    Soichiro Kiyono
    Masato Nakamura
    Naoya Kanogawa
    Tomoko Saito
    Takayuki Kondo
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Tetsuhiro Chiba
    Ei Itobayashi
    Masanori Atsukawa
    Yoshihiro Koma
    Ryosaku Azemoto
    Kenji Ito
    Hideaki Mizumoto
    Jun Kato
    Naoya Kato
    [J]. BMC Gastroenterology, 23
12345